{
    "clinical_study": {
        "@rank": "98953", 
        "arm_group": [
            {
                "arm_group_label": "MLN9708 plus Dexamethasone", 
                "arm_group_type": "Experimental", 
                "description": "Patients will receive MLN9708 (4.0 mg) orally (PO) on Days 1, 8, and 15 plus dexamethasone 20 mg/day PO weekly on Days 1, 8, 15, and 22 of each 28-day cycle; dexamethasone may be increased up to 40 mg/day after 4 weeks, if tolerated. Patients may continue to receive treatment until PD or unacceptable toxicity, whichever comes first."
            }, 
            {
                "arm_group_label": "Physician's Choice", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will receive one of the following treatment options as selected by the physician:\nDexamethasone: 20 mg/day orally (PO) on Days 1-4, 9-12 & 17- 20 of each 28-day cycle\nDexamethasone + melphalan: Dexamethasone 20 mg/day PO on Days 1-4 of each 28-day; plus melphalan 0.22 mg/kg PO on Days 1-4 every 28 days.\nDexamethasone + cyclophosphamide: Dexamethasone 20 mg/day PO weekly on Days 1, 8, 15 & 22 of each 28-day cycle; plus cyclophosphamide 500 mg PO Days 1, 8 & 15 every 28 days.\nDexamethasone + thalidomide: Dexamethasone 20 mg/day PO weekly Days 1, 8, 15 & 22 of each 28-day cycle; plus thalidomide total dose up to 200 mg/day PO\nDexamethasone + lenalidomide: Dexamethasone 20 mg/day PO weekly on Days 1, 8, 15 & 22 of each 28-day cycle; plus lenalidomide 15 mg/day for 21 days every 28 days.\nIn all treatments dexamethasone may be increased up to 40 mg/day after 4 weeks, if the lower dose is tolerated without any > Grade 2 dexamethasone-related toxicities."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a phase 3, randomized, controlled, open-label, multicenter study of the oral\n      formulation of dexamethasone plus MLN9708 compared with treatment chosen by the investigator\n      from a prespecified list of regimens available in clinical practice.  Treatment options will\n      include: dexamethasone alone, dexamethasone plus an alkylating agent (melphalan or\n      cyclophosphamide), or dexamethasone plus an immunomodulatory drug (IMiD, thalidomide or\n      lenalidomide) in patients with relapsed or refractory AL amyloidosis. Crossover to the\n      investigational treatment arm is not permitted during participation in this study."
        }, 
        "brief_title": "Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis", 
        "completion_date": {
            "#text": "August 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Relapsed or Refractory Systemic Light Chain Amyloidosis", 
        "condition_browse": {
            "mesh_term": "Amyloidosis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female patients 18 years or older\n\n          -  Biopsy-proven AL amyloidosis with relapsed or refractory disease despite 1 or 2 prior\n             therapies.  Patients may be proteasome inhibitor-exposed or naive, but cannot be\n             refractory to proteasome inhibitor therapy\n\n          -  Disease requiring further treatment\n\n          -  Measurable disease as defined by serum differential free light chain concentration\n             (dFLC)\n\n          -  Objective and measurable major organ involvement (ie, cardiac or renal) as defined by\n             the standard International Society of Amyloidosis (ISA) criteria.\n\n          -  Eastern Cooperative Oncology Group (ECOG) performance status of less than or equal to\n             2\n\n          -  Meet the clinical laboratories criteria as specified in the protocol\n\n          -  Female patients who are post menopausal, surgically sterile, or agree to practice 2\n             effective methods of contraception through 90 days after the last dose of study\n             treatment or agree to practice true abstinence; must also adhere to the guidelines of\n             any treatment specific pregnancy prevention program\n\n          -  Male patients who agree to practice effective barrier contraception through 90 days\n             after the last dose of study treatment or agree to practice true abstinence AND must\n             adhere to the guidelines of any treatment specific pregnancy prevention program\n\n          -  Voluntary written consent\n\n        Exclusion Criteria:\n\n          -  Amyloidosis due to mutations of the transthyretin gene or presence of other non-AL\n             amyloidosis\n\n          -  Female patients who are lactating, breastfeeding or pregnant\n\n          -  Evidence of current uncontrolled cardiovascular conditions as specified in study\n             protocol\n\n          -  Clinically overt multiple myeloma as specified in study protocol\n\n          -  Inability to swallow medication, inability or unwillingness to comply with the drug\n             administration requirements, or gastrointestinal (GI) procedure that could interfere\n             with the oral absorption or tolerance of treatment\n\n          -  Requirement for other concomitant chemotherapy, immunotherapy, radiotherapy, or any\n             ancillary therapy considered to be investigational or which would be considered as a\n             treatment of AL amyloidosis. However, patients may be on chronic steroids (maximum\n             dose 20 mg/day prednisone or equivalent if they are being given for disorders other\n             than amyloidosis\n\n          -  Comorbid systemic illnesses or other severe concurrent disease which, in the judgment\n             of the investigator, would make the patient inappropriate for entry into this study\n             or interfere significantly with the proper assessment of safety and toxicity of the\n             prescribed regimens\n\n          -  Ongoing or active infection, known HIV positive, active hepatitis B or C infection\n\n          -  Psychiatric illness/social situations that would limit compliance with study\n             requirements\n\n          -  Known allergy to any of the study medications, their analogues or excipients\n\n          -  Systemic treatment with strong inhibitors of CYP1A2, strong inhibitors of CYP3A, or\n             strong CYP3A inducers, or use of Ginkgo biloba or St. John's wort within 14 days\n             before the first dose of study treatment\n\n          -  Diagnosed or treated for another malignancy within 5 years before study enrollment or\n             previously diagnosed with another malignancy and have any evidence of residual\n             disease. Patients with nonmelanoma skin cancer or carcinoma in situ of any type are\n             not excluded if they have undergone complete resection"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "248", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01659658", 
            "org_study_id": "C16011", 
            "secondary_id": "2011-005468-10"
        }, 
        "intervention": [
            {
                "arm_group_label": "MLN9708 plus Dexamethasone", 
                "intervention_name": "MLN9708", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "MLN9708 plus Dexamethasone", 
                    "Physician's Choice"
                ], 
                "intervention_name": "Dexamethasone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Physician's Choice", 
                "intervention_name": "Melphalan", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Physician's Choice", 
                "intervention_name": "Cyclophosphamide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Physician's Choice", 
                "intervention_name": "Thalidomide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Physician's Choice", 
                "intervention_name": "Lenalidomide", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cyclophosphamide", 
                "Melphalan", 
                "Thalidomide", 
                "Lenalidomide", 
                "Dexamethasone", 
                "Dexamethasone acetate", 
                "Dexamethasone 21-phosphate", 
                "BB 1101"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "MLN9708", 
            "Amyloidosis", 
            "Light Chain"
        ], 
        "lastchanged_date": "September 13, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Reeder"
                }, 
                "facility": {
                    "address": {
                        "city": "Scottsdale", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85359"
                    }, 
                    "name": "Mayo Clinic Arizona"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Lill"
                }, 
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90048-18"
                    }, 
                    "name": "Cedars-Sinai Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Weston", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33331"
                    }, 
                    "name": "The Cleveland Clinic"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60637"
                    }, 
                    "name": "University of Chicago"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "IU Simon Cancer Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02118"
                    }, 
                    "name": "Boston Medical Center HEM/ONCO"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02111"
                    }, 
                    "name": "Tufts Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48201"
                    }, 
                    "name": "Barbara Ann Karmanos Cancer Institute"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Dispenzieri"
                }, 
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55905"
                    }, 
                    "name": "Mayo Clinic"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Heather Landau"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10017"
                    }, 
                    "name": "Memorial Sloan-Kettering Cancer Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "Abramson Cancer Center of Univ of Pennsylvania"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Goodman"
                }, 
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37232"
                    }, 
                    "name": "Vanderbilt University Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53226"
                    }, 
                    "name": "Froedtert & Medical College of Wisconsin"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Woolloongabba", 
                        "country": "Australia", 
                        "state": "Queensland", 
                        "zip": "QLD 4102"
                    }, 
                    "name": "Princess Alexandra Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Joshua"
                }, 
                "facility": {
                    "address": {
                        "city": "Camperdown, NSW", 
                        "country": "Australia", 
                        "zip": "2050"
                    }, 
                    "name": "Royal Prince Alfred Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nedlands", 
                        "country": "Australia", 
                        "zip": "6009"
                    }, 
                    "name": "Sir Charles Gairdner Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Kwok"
                }, 
                "facility": {
                    "address": {
                        "city": "Westmead, NSW", 
                        "country": "Australia", 
                        "zip": "2145"
                    }, 
                    "name": "Westmead Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Calgary", 
                        "country": "Canada", 
                        "state": "Alberta", 
                        "zip": "T2N 4N2"
                    }, 
                    "name": "Tom Baker Cancer Centre"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Kukreti"
                }, 
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5G2M9"
                    }, 
                    "name": "Princess Margaret Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "Canada", 
                        "zip": "V5Z1M9"
                    }, 
                    "name": "Vancouver General Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Niels Andersen"
                }, 
                "facility": {
                    "address": {
                        "city": "Aarhus", 
                        "country": "Denmark", 
                        "zip": "8000"
                    }, 
                    "name": "\u00c5rhus University Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jaccard"
                }, 
                "facility": {
                    "address": {
                        "city": "Limoges", 
                        "country": "France", 
                        "state": "Cedex", 
                        "zip": "87042"
                    }, 
                    "name": "CHU Limoges"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Leleu"
                }, 
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59037"
                    }, 
                    "name": "Hopital Huriez, CHRU"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Philippe Moreau"
                }, 
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France"
                    }, 
                    "name": "University Hospital Hotel-Dieu Nantes"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Fermand"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75010"
                    }, 
                    "name": "Hospital Saint Louis"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Dominique Chauveau"
                }, 
                "facility": {
                    "address": {
                        "city": "Toulouse Cedex 09", 
                        "country": "France", 
                        "zip": "31059"
                    }, 
                    "name": "CHU Rangueil"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "12200"
                    }, 
                    "name": "Charit\u00e9 Universit\u00e4tsmedizin Berlin"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Heidelberg", 
                        "country": "Germany", 
                        "zip": "69120"
                    }, 
                    "name": "University Hospital, Amyloidosis Center Med."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Kastritis"
                }, 
                "facility": {
                    "address": {
                        "city": "Athens", 
                        "country": "Greece", 
                        "zip": "11528"
                    }, 
                    "name": "General Hospital of Athens"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Symeonidis"
                }, 
                "facility": {
                    "address": {
                        "city": "Patras", 
                        "country": "Greece", 
                        "zip": "26500"
                    }, 
                    "name": "University General Hospital of Patras"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Gatt"
                }, 
                "facility": {
                    "address": {
                        "city": "Jerusalem", 
                        "country": "Israel", 
                        "zip": "91120"
                    }, 
                    "name": "Hadassah Medical Center - Hadassah University Hosp"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Hardan"
                }, 
                "facility": {
                    "address": {
                        "city": "Kfar Saba", 
                        "country": "Israel", 
                        "zip": "44281"
                    }, 
                    "name": "Meir Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Ofer Shpilberg"
                }, 
                "facility": {
                    "address": {
                        "city": "Petah-Tiqva", 
                        "country": "Israel", 
                        "zip": "49100"
                    }, 
                    "name": "Rabin Medical Center, Beilinson Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Cavo"
                }, 
                "facility": {
                    "address": {
                        "city": "Bologna", 
                        "country": "Italy", 
                        "zip": "40138"
                    }, 
                    "name": "Policlinico S. Orsola-Malpighi"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pavia", 
                        "country": "Italy", 
                        "zip": "27100"
                    }, 
                    "name": "Centro Amiloidosi Padiglione Forlanini - 3\u00b0 Piano"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Lee"
                }, 
                "facility": {
                    "address": {
                        "city": "Incheon", 
                        "country": "Korea, Republic of", 
                        "zip": "405-760"
                    }, 
                    "name": "Gachon University Gil Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "SungSoo Yoon"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Seoul National University Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Chang Ki Min"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Seoul St Mary's Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "KiHyun Kim"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Samsung Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1018 HV"
                    }, 
                    "name": "VUMC Ams VUMC Amsterdam"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Vellenga"
                }, 
                "facility": {
                    "address": {
                        "city": "Groningen", 
                        "country": "Netherlands", 
                        "zip": "9731 GZ"
                    }, 
                    "name": "Groningen Unit for Amyloidosis Research & Develop."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Gerard Bos"
                }, 
                "facility": {
                    "address": {
                        "city": "Maastricht", 
                        "country": "Netherlands"
                    }, 
                    "name": "Maastricht University Medical Centre"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Minnema"
                }, 
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands", 
                        "zip": "3508"
                    }, 
                    "name": "UMC Utrecht"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Blade"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08036"
                    }, 
                    "name": "Hospital Clinic I Provincial"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Alegre"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "2800"
                    }, 
                    "name": "Hospital Universitario de la Princesa"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Mateos"
                }, 
                "facility": {
                    "address": {
                        "city": "Salamanca", 
                        "country": "Spain", 
                        "zip": "37007"
                    }, 
                    "name": "University Hospital of Salamanca"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Ramasamy"
                }, 
                "facility": {
                    "address": {
                        "city": "Oxford", 
                        "country": "United Kingdom", 
                        "state": "Oxon", 
                        "zip": "OX3 7LE"
                    }, 
                    "name": "Oxford University Hospitals NHS Trust"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Wechalekar"
                }, 
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "NW3 2PF"
                    }, 
                    "name": "University College London Medica School"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Australia", 
                "Canada", 
                "Denmark", 
                "France", 
                "Germany", 
                "Greece", 
                "Israel", 
                "Italy", 
                "Korea, Republic of", 
                "Netherlands", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase 3, Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment Administered to Patients With Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis", 
        "overall_contact": {
            "email": "medical@mlnm.com", 
            "last_name": "For an updated listing of recruitment sites contact: Millennium Medical and Drug Information Center", 
            "phone": "1-877-674-3784"
        }, 
        "overall_official": {
            "affiliation": "Millennium Pharmaceuticals, Inc.", 
            "last_name": "Medical Monitor", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "European Union: European Medicines Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Complete response, very good partial response and partial response", 
                "measure": "Number of patients with overall hematologic response", 
                "safety_issue": "No", 
                "time_frame": "Assessed every 4 weeks (median length of the endpoint assessment period is projected to be approximately 36 months)"
            }, 
            {
                "description": "Rate of hospitalization for congestive heart failure or progression to end stage renal disease or death at 2 years", 
                "measure": "2-year vital organ deterioration and mortality rate", 
                "safety_issue": "No", 
                "time_frame": "Monthly for up to 2 years or until death"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01659658"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Overall complete hematologic response", 
                "measure": "Number of patients with complete hematologic response", 
                "safety_issue": "No", 
                "time_frame": "Assessed every 4 weeks (median length of the endpoint assessment period is projected to be approximately 36 months)"
            }, 
            {
                "description": "Time from randomization to the date of death", 
                "measure": "Overall survival", 
                "safety_issue": "No", 
                "time_frame": "Monthly up to 5 years"
            }, 
            {
                "description": "Time from date of randomization to the date of first documentation of disease progression or death, whichever occurs first", 
                "measure": "Progression free survival", 
                "safety_issue": "No", 
                "time_frame": "Monthly up to 5 years"
            }, 
            {
                "description": "Time from the date of randomization to the date of first documented hematologic disease progression or death, whichever occurs first", 
                "measure": "Hematologic disease progression free survival", 
                "safety_issue": "No", 
                "time_frame": "Monthly up to 5 years"
            }, 
            {
                "description": "Time from date of randomization to the first date of either death or hospitalization for congestive heart failure or progression to endstage renal disease", 
                "measure": "Time to vital organ deterioration and mortality rate", 
                "safety_issue": "No", 
                "time_frame": "Monthly up to 5 years"
            }, 
            {
                "description": "Overall organ response rate", 
                "measure": "Number of patients with cardiac and/or kidney response", 
                "safety_issue": "No", 
                "time_frame": "Every 3 cycles until disease progression"
            }, 
            {
                "description": "Time from the date of randomization to the date of first documentation of progression of vital organ, or death, whichever occurs first", 
                "measure": "Vital organ progression free survival", 
                "safety_issue": "No", 
                "time_frame": "Every 3 cycles until disease progression"
            }, 
            {
                "description": "Time from the date of first documentation of hematologic response to the date of first documented hematologic disease progression", 
                "measure": "Duration of hematologic response", 
                "safety_issue": "No", 
                "time_frame": "Monthly up to 5 years"
            }, 
            {
                "description": "Adverse events, serious adverse events, assessment of clinical laboratory values from the date of signing of the informed consent form through 30 days after the last dose of study drug.", 
                "measure": "Number of adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Monthly up to 5 years"
            }, 
            {
                "description": "Time from date of randomization to the date of first documented treatment failure", 
                "measure": "Time to treatment failure", 
                "safety_issue": "No", 
                "time_frame": "Monthly up to 5 years"
            }, 
            {
                "description": "Time from date of randomization to the start date of subsequent anticancer treatment", 
                "measure": "Time to subsequent anticancer treatment", 
                "safety_issue": "No", 
                "time_frame": "Monthly up to 5 years"
            }, 
            {
                "measure": "Results of Quality of Life Assessment", 
                "safety_issue": "No", 
                "time_frame": "At screening; Cycle 1, Day 1; Cycle 2, Day 1; Cycle 3, Day 1; Day 1 of every 3 cycles until disease progression"
            }, 
            {
                "description": "Number of admissions to an inpatient and outpatient setting for any reason (including length of stay, inpatient, outpatient, reason, number of missing days from work or other activities by patient or care-giver and EQ-5D scores questionnaire data", 
                "measure": "Number of medical encounters patient experiences", 
                "safety_issue": "No", 
                "time_frame": "At screening; Cycle 1, Day 1; Cycle 2, Day 1; Cycle 3, Day 1; Day 1 of every 3 cycles until disease progression"
            }, 
            {
                "description": "Pharmacokinetics", 
                "measure": "Time to reach plasma concentration", 
                "safety_issue": "No", 
                "time_frame": "Cycle 1, Days 1 and 14; Cycle 2, Days 1 and 14; Cycles 3-10, Day 1"
            }, 
            {
                "description": "Analysis of relevant signaling pathway genes in whole blood samples", 
                "measure": "Investigate the association of clinical outcomes and polymorphic genes", 
                "safety_issue": "No", 
                "time_frame": "At screening"
            }
        ], 
        "source": "Millennium Pharmaceuticals, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Millennium Pharmaceuticals, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}